We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,610

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTSI icon
13101
VirTra
VTSI
$36.5M
$11K ﹤0.01%
1,772
+1,207
+214% +$8.78K
CKPT
13102
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$11K ﹤0.01%
4,900
+4,500
+1,125% +$10.4K
DNTH icon
13103
CALL
Dianthus Therapeutics
DNTH
$6.49B
$11K ﹤0.01%
+400
New +$11.1K
DNTH icon
13104
PUT
Dianthus Therapeutics
DNTH
$6.49B
$11K ﹤0.01%
+400
New +$11.1K
HBT icon
13105
PUT
HBT Financial
HBT
$1.35B
$10.9K ﹤0.01%
500
+400
+400% +$8.76K
XNET
13106
CALL
Xunlei
XNET
$334M
$10.9K ﹤0.01%
5,900
+100
+2% +$165
OSBC icon
13107
PUT
Old Second Bancorp
OSBC
$1.32B
$10.9K ﹤0.01%
700
CUE icon
13108
CALL
Cue Biopharma
CUE
$144M
$10.9K ﹤0.01%
480
+53
+12% +$1.15K
IGF icon
13109
CALL
iShares Global Infrastructure ETF
IGF
$10.7B
$10.9K ﹤0.01%
+200
New +$10.2K
NTCT icon
13110
PUT
NETSCOUT
NTCT
$2.88B
$10.9K ﹤0.01%
500
+100
+25% +$1.97K
ILLRW
13111
Triller Group Inc Warrant
ILLRW
$936K
$10.8K ﹤0.01%
49,217
-22,845
-32% -$5.49K
BBAX icon
13112
CALL
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.75B
$10.8K ﹤0.01%
+200
New +$10K
ZH
13113
PUT
Zhihu
ZH
$273M
$10.8K ﹤0.01%
2,800
+304
+12% +$980
PRPL icon
13114
PUT
Purple Innovation
PRPL
$29.7M
$10.8K ﹤0.01%
436
+8
+2% +$231
CUT icon
13115
PUT
Invesco MSCI Global Timber ETF
CUT
$33.4M
$10.7K ﹤0.01%
+300
New +$10.1K
ACNT icon
13116
PUT
Ascent Industries
ACNT
$136M
$10.7K ﹤0.01%
+1,100
New +$10.8K
KZR
13117
CALL
DELISTED
Kezar Life Sciences
KZR
$10.7K ﹤0.01%
1,380
+1,060
+331% +$6.39K
INTR icon
13118
CALL
Inter&Co
INTR
$2.29B
$10.7K ﹤0.01%
1,600
-6,700
-81% -$46.3K
FWRD icon
13119
Forward Air
FWRD
$640M
$10.7K ﹤0.01%
+301
New +$8.54K
RLAY icon
13120
CALL
Relay Therapeutics
RLAY
$4.35B
$10.6K ﹤0.01%
1,500
-200
-12% -$1.49K
AZUL
13121
DELISTED
Azul
AZUL
$10.6K ﹤0.01%
3,070
-199,275
-98% -$749K
CTRM icon
13122
CALL
Castor Maritime
CTRM
$22.6M
$10.6K ﹤0.01%
+2,500
New +$11.6K
RSVR
13123
CALL
Reservoir Media
RSVR
$657M
$10.5K ﹤0.01%
1,300
+1,200
+1,200% +$9.16K
DTCK
13124
DELISTED
Davis Commodities
DTCK
$10.5K ﹤0.01%
+502
New +$11.8K
RRAC.WS
13125
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$10.5K ﹤0.01%
30,095
+4,135
+16% +$1.19K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.